AGILON HEALTH INC (AGL) Stock Earnings & Estimates
USA - New York Stock Exchange - NYSE:AGL - US00857U1079 - Common Stock
0.701 USD
+0.01 (+2.04%)
0.708 USD
+0.01 (+1%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.708B 47.70% | 4.316B 59.38% | 6.061B 40.41% | 5.879B -3.00% | 6.079B 3.40% | 6.744B 10.94% | 7.531B 11.67% | 9.033B 19.94% | 10.152B 12.39% | 7.989B -21.31% | |
| EBITDA YoY % growth | -106.63M 71.89% | -211.972M -98.79% | -264.071M -24.58% | -265.353M -0.49% | -109.49M 58.74% | -41.291M 62.29% | 35.467M 185.90% | 126.25M 255.96% | 203.72M 61.36% | 288.46M 41.60% | |
| EBIT YoY % growth | -120.4M 69.44% | -232.133M -92.80% | -288.534M -24.30% | -379.458M -31.51% | -205.264M 45.91% | -131.219M 36.07% | -39.087M 70.21% | 27.674M 170.80% | 102.72M 271.18% | 183.92M 79.05% | |
| Operating Margin | -4.45% | -5.38% | -4.76% | -6.45% | -3.38% | -1.95% | -0.52% | 0.31% | 1.01% | 2.30% | |
| EPS YoY % growth | -0.26 75.70% | -0.49 -88.46% | -0.63 -28.57% | -0.77 -21.58% | -0.42 44.90% | -0.26 38.74% | -0.15 43.36% | N/A | N/A | N/A |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.28 -6.66% | -0.03 -197.63% | -0.12 51.76% | -0.12 56.83% | -0.12 55.61% | 0.10 434.48% | -0.01 93.30% | -0.01 94.80% | -0.07 45.03% |
| Revenue Q2Q % growth | 1.475B -3.12% | 1.611B 5.10% | 1.492B 6.95% | 1.504B 4.78% | 1.631B 10.58% | 1.997B 23.96% | 1.945B 30.36% | 1.938B 28.86% | 2.045B 25.38% |
| EBITDA Q2Q % growth | -105.229M -30.88% | 7.615M 149.99% | -26.483M 73.99% | -31.848M 70.95% | -37.302M 64.55% | 53.754M 605.90% | -3.709M 86.00% | -4.523M 85.80% | -38.175M -2.34% |
| EBIT Q2Q % growth | -122.759M -17.58% | -20.15M 8.87% | -46.43M 59.98% | -56.029M 57.32% | -64.778M 47.23% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.27 6.90% | -0.16 | -0.11 | -68.86% |
| Q2 2025 Q2Q % growth | -0.25 -257.14% | -0.12 | -0.13 | -114.66% |
| Q1 2025 Q2Q % growth | 0.03 400.00% | -0.01 | 0.04 | 422.51% |
| Q4 2024 Q2Q % growth | -0.26 36.59% | -0.23 | -0.03 | -12.63% |
| Q3 2024 Q2Q % growth | -0.29 -262.50% | -0.11 | -0.18 | -171.08% |
| Q2 2024 Q2Q % growth | -0.07 -75.00% | -0.08 | 0.01 | 14.11% |
| Q1 2024 Q2Q % growth | -0.01 -125.00% | -0.01 | 0.00 | 18.64% |
| Q4 2023 Q2Q % growth | -0.41 -192.86% | -0.30 | -0.11 | -34.90% |
| Q3 2023 Q2Q % growth | -0.08 -14.29% | -0.06 | -0.02 | -39.16% |
| Q2 2023 Q2Q % growth | -0.04 20.00% | -0.03 | -0.01 | -55.98% |
| Q1 2023 Q2Q % growth | 0.04 | 0.02 | 0.02 | 81.50% |
| Q4 2022 Q2Q % growth | -0.14 | -0.09 | -0.05 | -61.18% |
| Q3 2022 Q2Q % growth | -0.07 22.22% | -0.05 | -0.02 | -38.61% |
| Q2 2022 Q2Q % growth | -0.05 93.67% | -0.02 | -0.03 | -175.03% |
| Q1 2022 Q2Q % growth | 0.00 100.00% | 0.00 | 0.00 | -100.00% |
| Q4 2021 Q2Q % growth | -0.14 | -0.11 | -0.03 | -26.01% |
| Q3 2021 Q2Q % growth | -0.09 | -0.10 | 0.01 | 7.82% |
| Q2 2021 Q2Q % growth | -0.79 | -0.06 | -0.73 | -1,322.14% |
| Q1 2021 Q2Q % growth | -0.05 | -0.03 | -0.02 | -65.02% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 1.435B -1.08% | 1.438B | -2.679M | -0.19% |
| Q2 2025 Q2Q % growth | 1.395B -5.92% | 1.486B | -91.018M | -6.13% |
| Q1 2025 Q2Q % growth | 1.533B -4.46% | 1.519B | 13.782M | 0.91% |
| Q4 2024 Q2Q % growth | 1.522B 44.16% | 1.531B | -8.514M | -0.56% |
| Q3 2024 Q2Q % growth | 1.451B 19.35% | 1.485B | -34.068M | -2.29% |
| Q2 2024 Q2Q % growth | 1.483B 29.04% | 1.575B | -92.242M | -5.86% |
| Q1 2024 Q2Q % growth | 1.604B 41.21% | 1.62B | -15.646M | -0.97% |
| Q4 2023 Q2Q % growth | 1.056B 53.10% | 1.028B | 28.073M | 2.73% |
| Q3 2023 Q2Q % growth | 1.216B 74.94% | 1.149B | 66.66M | 5.80% |
| Q2 2023 Q2Q % growth | 1.149B 71.47% | 1.122B | 27.052M | 2.41% |
| Q1 2023 Q2Q % growth | 1.136B 73.88% | 1.089B | 47.147M | 4.33% |
| Q4 2022 Q2Q % growth | 689.8M 49.02% | 671M | 18.8M | 2.80% |
| Q3 2022 Q2Q % growth | 694.9M 51.53% | 660.61M | 34.29M | 5.19% |
| Q2 2022 Q2Q % growth | 670.1M 34.29% | 654.46M | 15.64M | 2.39% |
| Q1 2022 Q2Q % growth | 653.4M 58.17% | 648.65M | 4.75M | 0.73% |
| Q4 2021 Q2Q % growth | 462.9M | 457.42M | 5.48M | 1.20% |
| Q3 2021 Q2Q % growth | 458.6M 46.66% | 454.85M | 3.75M | 0.82% |
| Q2 2021 Q2Q % growth | 499M 69.96% | 478.03M | 20.97M | 4.39% |
| Q1 2021 Q2Q % growth | 413.1M 41.96% | 409.55M | 3.55M | 0.87% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -8.06% | -36.44% | -24.42% | -18.01% |
| Revenue | -0.07% | 0.07% | 0.1% | 0.1% |